Correlation Between Supernus Pharmaceuticals and Merck KGaA
Can any of the company-specific risk be diversified away by investing in both Supernus Pharmaceuticals and Merck KGaA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Supernus Pharmaceuticals and Merck KGaA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Supernus Pharmaceuticals and Merck KGaA ADR, you can compare the effects of market volatilities on Supernus Pharmaceuticals and Merck KGaA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Supernus Pharmaceuticals with a short position of Merck KGaA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Supernus Pharmaceuticals and Merck KGaA.
Diversification Opportunities for Supernus Pharmaceuticals and Merck KGaA
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Supernus and Merck is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Supernus Pharmaceuticals and Merck KGaA ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Merck KGaA ADR and Supernus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Supernus Pharmaceuticals are associated (or correlated) with Merck KGaA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Merck KGaA ADR has no effect on the direction of Supernus Pharmaceuticals i.e., Supernus Pharmaceuticals and Merck KGaA go up and down completely randomly.
Pair Corralation between Supernus Pharmaceuticals and Merck KGaA
Given the investment horizon of 90 days Supernus Pharmaceuticals is expected to generate 1.19 times more return on investment than Merck KGaA. However, Supernus Pharmaceuticals is 1.19 times more volatile than Merck KGaA ADR. It trades about 0.09 of its potential returns per unit of risk. Merck KGaA ADR is currently generating about 0.04 per unit of risk. If you would invest 2,356 in Supernus Pharmaceuticals on January 25, 2024 and sell it today you would earn a total of 639.00 from holding Supernus Pharmaceuticals or generate 27.12% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Supernus Pharmaceuticals vs. Merck KGaA ADR
Performance |
Timeline |
Supernus Pharmaceuticals |
Merck KGaA ADR |
Supernus Pharmaceuticals and Merck KGaA Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Supernus Pharmaceuticals and Merck KGaA
The main advantage of trading using opposite Supernus Pharmaceuticals and Merck KGaA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Supernus Pharmaceuticals position performs unexpectedly, Merck KGaA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merck KGaA will offset losses from the drop in Merck KGaA's long position.Supernus Pharmaceuticals vs. Lifecore Biomedical | Supernus Pharmaceuticals vs. Lucy Scientific Discovery |
Merck KGaA vs. Recruit Holdings Co | Merck KGaA vs. Fresenius SE Co | Merck KGaA vs. Straumann Holding AG | Merck KGaA vs. MERCK Kommanditgesellschaft auf |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |